Rheumatology International

, Volume 29, Issue 8, pp 897–905 | Cite as

Predictors of bone density testing in patients with rheumatoid arthritis

Original Article


Patients with rheumatoid arthritis (RA) are at increased risk of low bone density and fractures. This study identifies predictors of initiation of dual energy X-ray absorptiometry (DXA) testing in RA. We identified RA patients from the CORRONA registry with ≥1 year follow-up without reported DXA at study entry. The primary outcome was report of DXA in the first year of follow-up (DXA initiation). Variables associated with DXA initiation were considered for the multivariate model. Stepwise logistic regression identified independent predictors. Of the 2,717 RA patients without DXA documented at enrollment, 297 (11%) reported DXA initiation. Independent predictors of DXA initiation included age, female sex, history of fracture, steroid use, and physician’s assessment of RA activity. In conclusion, DXA initiation in RA patients in the CORRONA cohort is low despite increased risk of osteoporosis. Predictors of DXA initiation include fracture, common risk factors for osteoporosis, and RA-associated factors.


Bone density Education Osteoporosis Rheumatoid arthritis 

Supplementary material

296_2008_804_MOESM1_ESM.doc (61 kb)
Supplemental Table A (DOC 430 kb)


  1. 1.
    Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35:309–322. doi:10.1093/rheumatology/35.4.309 PubMedCrossRefGoogle Scholar
  2. 2.
    Fontana SA, Baumann LC, Helberg C et al (1997) The delivery of preventive services in primary care practices according to chronic disease status. Am J Public Health 87:1190–1196PubMedCrossRefGoogle Scholar
  3. 3.
    Redelmeier DA, Tan SH, Booth GL (1998) The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 338:1516–1520. doi:10.1056/NEJM199805213382106 PubMedCrossRefGoogle Scholar
  4. 4.
    MacLean CH, Louie R, Leake B et al (2000) Quality of care for patients with rheumatoid arthritis. JAMA 284:984–992. doi:10.1001/jama.284.8.984 PubMedCrossRefGoogle Scholar
  5. 5.
    Pokrajac-Zirojevic V, Slack-Smith LM, Booth D (2002) Arthritis and use of dental services: a population based study. Aust Dent J 47:208–213. doi:10.1111/j.1834-7819.2002.tb00330.x PubMedCrossRefGoogle Scholar
  6. 6.
    Kremers HM, Bidaut-Russell M, Scott CG et al (2003) Preventive medical services among patients with rheumatoid arthritis. J Rheumatol 30:1940–1947PubMedGoogle Scholar
  7. 7.
    American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496–1503. doi:10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5CrossRefGoogle Scholar
  8. 8.
    Curtis JR, Westfall AO, Allison JJ et al (2005) Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum 52:2485–2494. doi:10.1002/art.21194 PubMedCrossRefGoogle Scholar
  9. 9.
    Solomon DH, Katz JN, Jacobs JP et al (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46:3136–3142. doi:10.1002/art.10613 PubMedCrossRefGoogle Scholar
  10. 10.
    van Staa TP, Geusens P, Bijlsma JW et al (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104–3112. doi:10.1002/art.22117 PubMedCrossRefGoogle Scholar
  11. 11.
    Osteoporosis: review of the evidence for prevention, diagnosis, treatment, cost-effectiveness analysis (1998) Executive summary. Osteoporos Int 8:S3–S6Google Scholar
  12. 12.
    National Osteoporosis Foundation (NOF). The Clinician’s Guide to Prevention and Treatment of Osteoporosis. In: http://www.nof.org/professionals/NOF_Clinicians%20_guide.pdf
  13. 13.
    The International Society for Clinical Densitometry—Official Positions. In: http://www.iscd.org/Visitors/positions/OfficialPositionsText.cfm
  14. 14.
    Leib ES, Lewiecki EM, Binkley N et al (2004) Official positions of the International Society for Clinical Densitometry. J Clin Densitom 7:1–6. doi:10.1385/JCD:7:1:1 PubMedCrossRefGoogle Scholar
  15. 15.
    World Organisation (2007) World Health Organisation Scientific Group on the assessment of osteoporosis at the primary health care level. Summary Meeting Report. In: http://www.nof.org/professionals/WHO_Osteoporosis_Summary.pdf
  16. 16.
    FRAXTM—WHO Fracture Risk Assessment Tool. In: http://www.shef.ac.uk/FRAX/
  17. 17.
    Siris E, Delmas PD (2008) Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos Int 19:383–384. doi:10.1007/s00198-008-0564-8 PubMedCrossRefGoogle Scholar
  18. 18.
    Tosteson ANA, Melton LJ III, Dawson-Hughes B et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447. doi:10.1007/s00198-007-0550-6 PubMedCrossRefGoogle Scholar
  19. 19.
    Kjeken I, Dagfinrud H, Mowinckel P et al (2006) Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 55:394–401. doi:10.1002/art.21985 PubMedCrossRefGoogle Scholar
  20. 20.
    Callahan LF, Pincus T (1988) Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 31:1346–1357. doi:10.1002/art.1780311102 PubMedCrossRefGoogle Scholar
  21. 21.
    Odegard S, Finset A, Kvien TK et al (2005) Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol 34:441–447. doi:10.1080/03009740510018633 PubMedCrossRefGoogle Scholar
  22. 22.
    Morales-Romero J, Gonzalez-Lopez L, Celis A et al (2006) Factors associated with permanent work disability in Mexican patients with rheumatoid arthritis. A case-control study. J Rheumatol 33:1247–1249PubMedGoogle Scholar
  23. 23.
    Pincus T, Keysor J, Sokka T et al (2004) Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 31:229–234PubMedGoogle Scholar
  24. 24.
    Kremer JM (2006) The CORRONA database. Autoimmun Rev 5:46–54. doi:10.1016/j.autrev.2005.07.006 PubMedCrossRefGoogle Scholar
  25. 25.
    Tutunco Z, Reed G, Kremer J et al (2006) Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 65:1226–1229. doi:10.1136/ard.2005.051144 CrossRefGoogle Scholar
  26. 26.
    Greenberg JD, Bingham CO III, Abramson SB et al (2005) Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Arthritis Rheum 53:12–17. doi:10.1002/art.20905 PubMedCrossRefGoogle Scholar
  27. 27.
    Greenberg JD, Bingham CO III, Abramson SB et al (2006) Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals. Arthritis Rheum 55:543–550. doi:10.1002/art.22095 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • J. Aizer
    • 1
  • G. Reed
    • 2
  • A. Onofrei
    • 2
  • M. J. Harrison
    • 3
  1. 1.Division of Rheumatology, Hospital for Special Surgery Weill Cornell Medical CollegeNew YorkUSA
  2. 2.Biostatistics Research Group, Division of Preventive and Behavioral Medicine, Department of MedicineUniversity of MassachusettsWorcesterUSA
  3. 3.Department of EpidemiologyWyeth ResearchCollegevilleUSA

Personalised recommendations